Abstract: The present invention relates to a probe for insertion in the anal canal (canalis analis) and rectum of a body for the purpose of examining and treating patients suffering from diseases therein. More specifically, the invention relates to a probe for use in treatment of patients suffering from anal incontinence by injection of a bulking agent for obtaining a restricted fecal/flatus passageway in the anal canal.

Abstract: A sheath device (1) suitable for endoscopic instruments (2) and comprising an elongated tubular member (4) having a proximal end (6), a distal open end (7), and at least one fluid channel (23). A flushing unit (5) is connected to the proximal end (6) of the tubular member (4) and comprises a proximal open end (8) suitable for receiving a first endoscopic instrument (2), a fluid inlet (16) in contact with said fluid channel (23), and a fluid outlet (17). The tubular member and the flushing unit together define a first interior guiding passage (10) for sheathing at least a part of said first endoscopic instrument (2). The connection between the tubular member (4) and the flushing unit (5) allows for axial rotation of the tubular member (4) in relation to the flushing unit (5).

Abstract: An apparatus for preparing a concentrate of coagulation factors, such as fibrinogen, from a blood sample, comprises a first chamber (14) for collection and separation of said blood sample so as to separate a plasma fraction, and a second chamber (15) for collection of said plasma fraction through a tubing member (22, 30) and a valve (24) and for precipitation of said concentrate. The apparatus comprises furthermore a .removable syringe (36) for receiving the concentrate from the second chamber (15) through a tubing member (32). The first and the second chamber (14, 15) are partially defined by the same integrally formed solid container wall (2) and comprise a common partition. The first chamber (14) is further defined by a piston (4) displaceable both in connection with the blood sample collection and the transfer of said plasma fraction to the second chamber (15) and in connection with returning said plasma fraction to the first chamber (14) upon the precipitation of the concentrate.